Stockreport

IO Biotech Announces Exploration of Strategic Alternatives

IO Biotech, Inc.  (IOBT) 
PDF NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf th [Read more]